Skip to content

NewAmsterdam Pharma

US · NAMS #2583 by market cap Listed 1970
18.41 -1.10 -5.64%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Quant vs Street three independent views, side by side

StockVane factor grade
C-
Momentum strategy signal
Strong Sell
Analyst consensus
Buy

Signals diverge - worth digging into why.

Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.

Analyst consensus 10 analysts

Buy
Avg price target 54.44 +195.7%
Price target rangecurrent 18.41
Low42.00
Avg54.44
High61.00
Buy 100% Hold 0% Sell 0%
Recent ratings (25)
DateFirmAnalystRatingTarget
2026-11-10 Cantor Fitzgerald -- Buy 61.00
2026-11-09 Piper Sandler -- Buy 60.00
2026-11-09 Stifel -- Buy 50.00
2026-11-06 H.C. Wainwright -- Buy 52.00
2026-11-05 Wells Fargo -- Buy 55.00
2026-11-05 BMO Capital -- Buy 58.00
2026-11-04 RBC Capital -- Buy 42.00
2026-10-15 Citi -- Buy 55.00
2026-10-05 RBC Capital -- Buy 42.00
2026-10-02 Wells Fargo -- Buy 55.00
2026-09-29 H.C. Wainwright -- Buy 52.00
2026-09-22 Truist Financial -- Buy 57.00
2026-09-21 BMO Capital -- Buy 58.00
2026-09-21 H.C. Wainwright -- Buy 52.00
2026-09-18 William Blair -- Buy --
2026-09-08 Truist Financial -- Buy --
2026-09-08 Stifel -- Buy 50.00
2026-09-08 H.C. Wainwright -- Buy 52.00
2026-08-07 Needham -- Buy 48.00
2026-08-06 William Blair -- Buy --
2026-08-06 Truist Financial -- Buy --
2026-08-06 Stifel -- Buy 50.00
2026-08-06 H.C. Wainwright -- Buy 52.00
2026-08-05 BMO Capital -- Buy 58.00
2026-08-05 RBC Capital -- Buy 50.00

Price target trend monthly average, last 3 years

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

NewAmsterdam Pharma discussion 0 comments

Add a comment